HYUNDAI BIOLAND Co.Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.102x

HYUNDAI BIOLAND Co.Ltd cash flow conversion efficiency. Based on the latest financial reports, HYUNDAI BIOLAND Co.Ltd (052260) has a cash flow conversion efficiency ratio of 0.102x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩14.09 Billion ≈ $9.55 Million USD) by net assets (₩137.95 Billion ≈ $93.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of HYUNDAI BIOLAND Co.Ltd (2011–2024)

Cash flow conversion efficiency of HYUNDAI BIOLAND Co.Ltd from 2011 to 2024. This chart illustrates how HYUNDAI BIOLAND Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 052260 share price today for real-time trading data and today's change.

HYUNDAI BIOLAND Co.Ltd Cash Flow Conversion Ratio Explained

HYUNDAI BIOLAND Co.Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

HYUNDAI BIOLAND Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of HYUNDAI BIOLAND Co.Ltd ranked by their cash flow conversion efficiency. Also see 052260 stock market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Bioptik Technology
TWO:4161
0.055x
Wiable Corp
KQ:065530
-0.020x
GBK Beteiligungen AG
HM:GBQ
N/A
Creas F&C Co.Ltd
KQ:110790
-0.010x
Prescient Therapeutics Ltd
AU:PTX
-0.386x
Piolink Inc
KQ:170790
0.042x
DYPNF Co.Ltd
KQ:104460
-0.090x
IZEA Inc
NASDAQ:IZEA
0.024x

Annual Cash Flow Conversion Efficiency for HYUNDAI BIOLAND Co.Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of HYUNDAI BIOLAND Co.Ltd from 2011 to 2024. Review HYUNDAI BIOLAND Co.Ltd (052260) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩138.01 Billion
≈ $93.53 Million
₩4.60 Billion
≈ $3.12 Million
0.033x -18.86%
2023-12-31 ₩135.98 Billion
≈ $92.15 Million
₩5.59 Billion
≈ $3.79 Million
0.041x -53.04%
2022-12-31 ₩129.29 Billion
≈ $87.62 Million
₩11.31 Billion
≈ $7.67 Million
0.087x -48.93%
2021-12-31 ₩125.35 Billion
≈ $84.95 Million
₩21.48 Billion
≈ $14.55 Million
0.171x +162.43%
2020-12-31 ₩137.23 Billion
≈ $93.00 Million
₩8.96 Billion
≈ $6.07 Million
0.065x -10.45%
2019-12-31 ₩155.72 Billion
≈ $105.53 Million
₩11.35 Billion
≈ $7.69 Million
0.073x -31.58%
2018-12-31 ₩148.91 Billion
≈ $100.91 Million
₩15.87 Billion
≈ $10.75 Million
0.107x +4.79%
2017-12-31 ₩137.82 Billion
≈ $93.40 Million
₩14.01 Billion
≈ $9.50 Million
0.102x +3.39%
2016-12-31 ₩130.53 Billion
≈ $88.46 Million
₩12.84 Billion
≈ $8.70 Million
0.098x +5.23%
2015-12-31 ₩121.82 Billion
≈ $82.55 Million
₩11.38 Billion
≈ $7.71 Million
0.093x -13.83%
2014-12-31 ₩114.48 Billion
≈ $77.58 Million
₩12.42 Billion
≈ $8.41 Million
0.108x -32.23%
2013-12-31 ₩107.40 Billion
≈ $72.78 Million
₩17.19 Billion
≈ $11.65 Million
0.160x +35.42%
2012-12-31 ₩100.65 Billion
≈ $68.21 Million
₩11.90 Billion
≈ $8.06 Million
0.118x -28.25%
2011-12-31 ₩93.29 Billion
≈ $63.22 Million
₩15.37 Billion
≈ $10.41 Million
0.165x --

About HYUNDAI BIOLAND Co.Ltd

KQ:052260 Korea Personal & Household Products & Services
Market Cap
$39.44 Million
₩58.20 Billion KRW
Market Cap Rank
#22568 Global
#1466 in Korea
Share Price
₩3880.00
Change (1 day)
-5.25%
52-Week Range
₩3225.00 - ₩5670.00
All Time High
₩21553.60
About

HYUNDAI BIOLAND Co.,Ltd manufactures and sells raw materials for cosmetics, nutraceuticals, and regenerative medicines. It offers anti-aging, moisturizing, whitening, skin protection, and other cosmetic ingredients; functional food ingredients and general food raw materials; and active pharmaceutical ingredients. The company was formerly known as SKbioland Co., Ltd. and changed its name to HYUNDA… Read more